Health
FDA to Review Safety Data for AstraZeneca COVID-19 Vaccine – Contagionlive.com
The agency requested data this week, following the pause of large-scale international assessment after a non-fatal serious adverse event was reported in a UK pa…
Scrutiny into the safety of the AstraZeneca and University of Oxford investigative coronavirus 2019 (COVID-19) vaccine candidate has not yet been eased.The US Food and Drug Administration (FDA) has started investigation into a serious adverse event reported by a UK-based volunteer participant in the phase 3 trial for adenovirus AZD1222, initially reported in the first week of September.
According to Reuters, the agency anticipates to receive requested safety data later this week, at which time …
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
General14 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
Business12 hours ago10 ASX shares to buy after the market selloff